T6	Subject 0 35	Two patients with adrenal carcinoma
T8	Treatment 49 118	2,2-bis (2-chlorophenyl-4-chlorophenyl)-1,1-dichloroethane (o,p'-DDD)
T9	Population 0 3	Two
T10	Sub-Disorder 18 35	adrenal carcinoma
T11	Drug 49 107	2,2-bis (2-chlorophenyl-4-chlorophenyl)-1,1-dichloroethane
